Recent News

• 05.30.2025 - Processa Pharmaceuticals Announces Presentation and Publication of Three Abstracts at 2025 ASCO Annual Meeting
• 05.30.2025 - Processa Pharmaceuticals Announces Presentation and Publication of Three Abstracts at 2025 ASCO Annual Meeting
• 04.15.2025 - Processa Pharmaceuticals’ Dr. David Young to Present at World Orphan Drug Congress USA 2025
• 04.15.2025 - Processa Pharmaceuticals’ Dr. David Young to Present at World Orphan Drug Congress USA 2025
• 03.18.2025 - Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference
• 03.18.2025 - Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference

Recent Filings

• 05.15.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 05.12.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 05.12.2025 - DEF 14A Other definitive proxy statements
• 05.08.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.01.2025 - PRE 14A Other preliminary proxy statements
• 04.11.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.11.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.11.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.11.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.20.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]